GARDprotein demonstrates exceptional ability to identify allergens in foodstuff – new research results presented at scientific conference.
Lund, 10th October 2017 – SenzaGen (Nasdaq First North: SENZA) today announces positive results from an evaluation of GARDprotein, a test method which is developed to make it possible to eliminate allergenic proteins from today's and tomorrow's foodstuffs. GARDprotein has the potential to open up a new market for SenzaGen's test platform. The results are being presented at the 3rd ImpARAS Conference in Helsingør, Denmark.The results being reported at the conference show that GARDprotein has a unique ability to distinguish two almost identical proteins, one allergenic and the other non-